Radiopharmaceuticals Bring in Big Money to Target Irreversible Tumo...
Biospace,
Pictured: Illustration of cancer cells being held in the crosshairs of a scope/iStock, wildpixel The final big M
Showing items 1–100
Thermo Fisher Scientific推出類腫瘤培養基，加速新型癌症治療方法的研發
Business Wire,
Gibco™ OncoPro™類腫瘤培養基套件擴大了獲得臨床相關的患者源性腫瘤模型的途徑 加州卡爾斯巴德--(BUSINESS WIRE)--(美國商業資訊)-- 全球科學服務領導者Thermo Fisher Scientific今日宣布推出，這是首個專門為…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Biz Wire Express,
Thermo Fisher (BusinessWire India) 2023-06-29 Business Wire India Thermo Fisher Scientific, the world leader in serving science…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Businessfortnight,
Carlsbad, Calif., United States: Thermo Fisher Scientific, the world leader in serving science, today announced the launch of…
Comunicado do Business Wire :Thermo Fisher Há 15min
O POVO,
A Thermo Fisher Scientific, a líder mundial em servir a ciência, anunciou hoje o lançamento do Gibco? OncoPro? Tumoroid Culture…
Thermo Fisher Scientific apresenta meio de cultura para tumoroides para acelerar o desenvolvimento de novas terapias contra o câncer
Business Wire,
O Gibco™ OncoPro™ Tumoroid Culture Medium Kit amplia o acesso a modelos de tumor clinicamente relevantes derivados de pacientes…
Thermo Fisher Scientific推出肿瘤培养基，加速新型癌症治疗方法的开发
Business Wire,
Gibco™ OncoPro™肿瘤培养基试剂盒拓宽了临床相关患者来源肿瘤模型的获取途径 加州卡尔斯巴德--(BUSINESS WIRE)--(美国商业资讯)-- 全球科学服务领导企业Thermo Fisher Scientific今日宣布推出Gibco™…
サーモフィッシャーサイエンティフィック、腫瘍オルガノイド培養液を発表、新規がん治療開発を加速へ
Business Wire,
Gibco™ OncoPro™ 腫瘍オルガノイド培養液キットにより、臨床関連で患者由来の腫瘍モデルへのアクセスが広がる カリフォルニア州カールスバッド--(BUSINESS WIRE)--（ビジネスワイヤ） -- 科学サービスの世界的リーダー企業であるサーモ…
Thermo Fisher Scientific apresenta meio de cultura para tumoroides para acelerar o desenvolvimento de novas terapias contra o câncer
Bakersfield,
CARLSBAD, Califórnia--(BUSINESS WIRE)--jun 28, 2023-- A Thermo Fisher Scientific, a líder mundial em servir a ciência, anunciou…
News story from Finanz Nachrichten on Wednesday 28 June 2023
Finanz Nachrichten,
Thermo Fisher Scientific führt Tumoroid-Kulturmedium ein, um die Entwicklung neuartiger Krebstherapien zu beschleunigen
Business Wire,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit erweitert den Zugang zu klinisch relevanten Tumormodellen, die von Patienten…
Thermo Fisher Scientific führt Tumoroid-Kulturmedium ein, um die Entwicklung neuartiger Krebstherapien zu beschleunigen
Bakersfield,
- Thermo Fisher Scientific, das weltweit führende Unternehmen im Dienste der Wissenschaft, gab heute die Markteinführung des…
Thermo Fisher Scientific presenta el medio de cultivo de organoides similares a un tumor para acelerar el desarrollo de nuevos tratamientos contra el cáncer
La Nacion,
CARLSBAD, California--(BUSINESS WIRE)--jun. 28, 2023-- Thermo Fisher Scientific, líder mundial en la ciencia de los servicios…
Thermo Fisher Scientific lance un milieu de culture tumoroïde pour accélérer le développement de nouveaux traitements contre le cancer
Le Lézard,
Thermo Fisher Scientific, leader mondial au service de la science, a annoncé aujourd'hui le lancement du kit Gibcotm OncoProtm…
Thermo Fisher Scientific lance un milieu de culture tumoroïde pour accélérer le développement de nouveaux traitements contre le cancer
Business Wire,
Le kit Gibco™ OncoPro™ Tumoroid Culture Medium élargit l'accès à des modèles de tumeurs provenant de patients cliniquement…
Thermo Fisher Scientific presenta el medio de cultivo de organoides similares a un tumor para acelerar el desarrollo de nuevos tratamientos contra el cáncer
Business Wire,
El amplía el acceso a modelos tumorales clínicamente relevantes derivados de pacientes CARLSBAD, California--(BUSINESS WIRE)--The…
Thermo Fisher Scientific lance un milieu de culture tumoroïde pour accélérer le développement de nouveaux traitements contre le cancer
Bakersfield,
CARLSBAD, Californie--(BUSINESS WIRE)--juin 28, 2023-- Thermo Fisher Scientific, leader mondial au service de la science, a…
Thermo Fisher Scientific presenta el medio de cultivo de organoides similares a un tumor para acelerar el desarrollo de nuevos tratamientos contra el cáncer
Bakersfield,
CARLSBAD, California--(BUSINESS WIRE)--jun. 28, 2023-- Thermo Fisher Scientific, líder mundial en la ciencia de los servicios…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Pharmaceutical Daily,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Fox 40,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
AFP,
CARLSBAD, Calif. Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Gibco™ OncoPro™…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
VB Profiles,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Spoke,
CARLSBAD, Calif.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today announced the launch…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Morning Star,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models Thermo Fisher…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Le Lézard,
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Gibcotm OncoProtm Tumoroid…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Benzinga,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models Thermo Fisher…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
ANSA.it,
Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Gibco OncoPro Tumoroid Culture…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Yahoo! Finance USA,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Business Wire,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.…
Thermo Fisher Scientific Introduces Tumoroid Culture Medium to Accelerate Development of Novel Cancer Therapies
Biospace,
Gibco™ OncoPro™ Tumoroid Culture Medium Kit broadens access to clinically relevant patient-derived tumor models CARLSBAD, Calif.…
See the 14-slide pitch deck that Meliora Therapeutics used to raise $11 million toward its search for more precise and effective cancer treatments
Business Insider,
Cancer treatments are difficult to develop and bring to market — the vast majority of them fail.
Many medications affect more than one target in the body
ASBMB,
Drugs don’t always behave exactly as expected. While researchers may develop a drug to perform one specific function that’s…
Many medications affect more than one target in the body; some drug designers embracing 'side effects'
Japan Today,
Drugs don’t always behave exactly as expected. While researchers may develop a drug to perform one specific function that’s…
Many medications affect more than one target in the body: Some drug designers are embracing the 'side effects'
MedicalXpress,
Drugs don't always behave exactly as expected. While researchers may develop a drug to perform one specific function that's…
Many medications affect more than one target in the body some drug designers are embracing the 'side effects' that had been seen as a drawback
Arizona Daily Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
The Southern Illinoisan,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Gregory Way…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
The Bismarck Tribune,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Gregory Way…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Rapid City Journal,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Gregory Way…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Beatrice Daily Sun,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Gregory Way…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Columbus Telegram,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Gregory Way…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Newsbreak,
Drugs don’t always behave exactly as expected. While researchers may develop a drug to perform one specific function that’s…
Many medications affect more than one target in the body - some drug designers are embracing the 'side effects' that had been seen as a drawback
Daily Magazine,
Drugs don't always behave exactly as expected. While researchers may develop a drug to perform one specific function that's…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
New Canaan Advertiser,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Houston Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Many medications affect more than one target in the body – some drug designers are embracing the ‘side effects’ that had been seen as a drawback
Global Advisors,
Depending on how you look at it, drugs that can act on multiple targets could be a boon instead of a challenge.
Many medications affect more than one target in the body – some drug designers are embracing the 'side effects' that had been seen as a drawback
Yahoo! News,
Drugs don’t always behave exactly as expected. While researchers may develop a drug to perform one specific function that’s…
HDACs, Illuminated
Science Magazine,
"It's not the things you don't know that get you", goes the old saying, "it's the things you know that just aren't so".
Repurposing generic drugs can reduce the time and cost to develop new treatments
Technology.org,
Discovering new ways to use existing drugs can come about intentionally or by chance.
Repurposing generic drugs can reduce time and cost to develop new treatments, but low profitability remains a barrier
MedicalXpress,
Credit: CC0 Public Domain Discovering new ways to use existing drugs can come about intentionally or by chance.
Repurposing Generic Drugs Can Reduce Time and Cost to Develop New Treatments – but Low Profitability Remains a Barrier
Hareetz ,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Fox News 26,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Columbus Telegram,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
goskagit.com,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments but low profitability remains a barrier
Arizona Daily Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Lincoln Journal Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Rapid City Journal,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
The Buffalo News,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
St. Louis Post-Dispatch,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Dispatch-Argus,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Global Advisors,
From thalidomide to Viagra, drug repurposing salvaged failed treatments by giving them new targets.
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Bozeman Daily Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
The Bismarck Tribune,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Idaho Press,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Shelton Herald,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
San Antonio Express-News,
(THE CONVERSATION) Discovering new ways to use existing drugs can come about intentionally or by chance.
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Jonathan…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Houston Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
The Conversation,
Discovering new ways to use existing drugs can come about intentionally or by chance.
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
New Canaan Advertiser,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
The Darien Times,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Repurposing generic drugs can reduce time and cost to develop new treatments – but low profitability remains a barrier
Yahoo! News,
Discovering new ways to use existing drugs can come about intentionally or by chance.
90% of drugs fail clinical trials
ASBMB,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
Phil's Stock World,
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates The majority of drug failures…
90% of drugs fail clinical trials: Here's one way researchers can select better drug candidates
Japan Today,
It takes 10 to 15 years and around $1 billion to develop one successful drug. Despite these significant investments in time and…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
KRQE,
( THE CONVERSATION ) It takes 10 to 15 years and around US$1 billion to develop one successful drug.
There's a Reason 90% of Drugs Fail Clinical Trials, And We Can Fix It
Science Alert,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials. Here's a method for selecting better drug candidates
MedicalXpress,
With each successive step of the drug development process, the probability of success gets increasingly smaller.
90% of Drugs Fail Clinical Trials – Here's One Way Researchers Can Select Better Drug Candidates
Hareetz ,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Yahoo! News,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials - here's one way researchers can select better drug candidates
Daily Magazine,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
goskagit.com,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
The Buffalo News,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Columbus Telegram,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Dispatch-Argus,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
St. Louis Post-Dispatch,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Idaho Press,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Arizona Daily Star,
contributed AP (The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Lincoln Journal Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Newsbreak,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
Global Advisors,
The majority of drug failures are attributed to lack of clinical efficacy and high toxicity.
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Bozeman Daily Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
The Bismarck Tribune,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Shelton Herald,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
New Canaan Advertiser,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
The Darien Times,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
San Antonio Express-News,
(THE CONVERSATION) It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Duxin Sun…
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
The Conversation,
It takes 10 to 15 years and around US$1 billion to develop one successful drug.
90% of drugs fail clinical trials – here's one way researchers can select better drug candidates
Fairfield Citizen,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
Malignancies of Cancer Research and Why Onco-Therapeutic Development is Failing Us
Medium US,
Thousands of cancer researchers worldwide pipette media solutions, culture cells, and conduct experiments in the hopes of…
Showing items 1–100